GLP-1 medications have become extremely popular for weight loss and diabetes management. Medications such as semaglutide and tirzepatide have helped many patients lose a significant amount of weight and improve their overall health.
At The Gabel Center for Hair Restoration in Portland, Oregon, we are seeing more patients who are taking GLP-1 medications and are also noticing hair shedding or thinning. That does not mean every patient on these medications will lose hair. It also does not mean the medication is always the direct cause. But this concern is coming up more often, and it deserves a careful discussion.
A recent study published in the Journal of the American Academy of Dermatology looked at this issue. The authors reviewed 283 patients taking GLP-1 receptor agonist medications who were seen in a dermatology clinic. Of those patients, 35 experienced hair loss.
The study does not prove that GLP-1 medications directly cause hair loss. Still, it supports what many physicians who treat hair loss are beginning to notice: some patients taking these medications are reporting new or worsening shedding.
What Types of Hair Loss Were Seen in Patients Taking GLP-1 Medications?
The study reported different types of hair loss, including androgenetic alopecia and telogen effluvium.
Androgenetic Alopecia
Androgenetic alopecia is the common genetic form of hair loss. In men, it often affects the hairline, frontal scalp, midscalp, and crown. This presentation is known as male pattern hair loss. In women, it often presents as gradual thinning through the central scalp or widening of the part line, while the frontal hairline is often preserved. This presentation is known as female pattern hair loss.
Telogen Effluvium
Telogen effluvium is different. This is a shedding condition that can occur after stress on the body. Common triggers include illness, surgery, rapid weight loss, reduced calorie intake, low protein intake, or nutritional deficiencies.
This is important because many patients taking GLP-1 medications are losing weight, sometimes quickly. When the body goes through a significant change, the hair cycle can be disrupted. More hairs can shift into the resting phase, and shedding may appear a few months later. Patients often notice more hair in the shower, on the pillow, or in the brush.
Is the GLP-1 Medication Causing the Hair Loss?
This is the key question. The honest answer is that we do not know for sure.
In some patients, the GLP-1 medication may be part of the story. In other patients, the hair loss may be more related to the weight loss itself, a lower protein intake, reduced overall nutrition, or an underlying hair loss condition that was already present.
That distinction matters. Not all hair loss is the same, and it should not all be treated the same way.
A patient with diffuse shedding after rapid weight loss may have telogen effluvium. A patient with gradual thinning in a recognizable pattern may have androgenetic alopecia. Some patients have both. A GLP-1 medication, weight loss, nutritional changes, and genetic hair loss can all overlap.
That is why simply blaming the medication may miss the bigger picture.
Why Proper Diagnosis Matters
Patients should not stop a GLP-1 medication on their own because of hair shedding. These medications may be prescribed for important medical reasons, including diabetes, obesity, and cardiovascular risk reduction. Any decision about continuing, changing, or stopping the medication should be made with the prescribing physician.
From a hair loss standpoint, the first step is a proper evaluation. Important factors include:
- When the shedding started
- How much weight has been lost
- How quickly the weight loss occurred
- Diet and protein intake
- Medical history and family history
- Scalp findings
- Whether the thinning is diffuse or patterned
At The Gabel Center for Hair Restoration in Portland, Oregon, consultations are performed personally by Dr. Gabel, and the diagnosis is made by Dr. Gabel, not by a salesperson or non-medical consultant. That matters. Hair loss diagnosis requires medical training, a careful scalp examination, and an understanding of the different conditions that can cause shedding or thinning, including telogen effluvium and androgenetic alopecia. A medical diagnosis can only be made by an appropriately licensed healthcare professional.
Dr. Gabel closely examines the scalp and, when appropriate, performs detailed trichoscopy and digital scalp analysis to better understand the pattern, severity, and likely cause of hair loss. Laboratory testing may also be appropriate when nutritional deficiency, thyroid disease, or iron deficiency is suspected.
The goal is straightforward: make the correct diagnosis before recommending treatment.
What This Study Means for Patients Taking Semaglutide or Tirzepatide
The recent dermatology study does not prove that GLP-1 medications directly cause hair loss. But it does show that hair loss is being reported in some patients taking these medications. In the study, 35 of 283 patients using GLP-1 receptor agonists experienced hair loss, and semaglutide and tirzepatide appeared to stand out as medications that deserve further research.
For patients, the message is simple. Hair shedding while taking a GLP-1 medication should be taken seriously, but it should be evaluated carefully. The cause may be rapid weight loss, nutrition, telogen effluvium, androgenetic alopecia, the medication itself, or a combination of factors.
The goal is not to scare patients away from GLP-1 medications. These medications can be very helpful for the right patient. But if new or worsening hair shedding develops, it should not be ignored.
Key Takeaways for Patients on GLP-1 Medications
GLP-1 medications have helped many patients improve their health, but some patients may notice hair shedding during treatment. The current evidence does not prove a direct cause-and-effect relationship, but the concern is real.
Hair loss is often multifactorial. In patients taking GLP-1 medications, the cause may involve weight loss, nutritional changes, telogen effluvium, androgenetic alopecia, or other medical issues. That is why the type of hair loss matters more than the medication alone, and why an accurate diagnosis should come before any treatment decision.
Schedule a Hair Loss Evaluation with Dr. Gabel in Portland, Oregon
If you are taking a GLP-1 medication such as semaglutide or tirzepatide and have noticed new or worsening hair shedding, do not guess the cause and or stop taking medication on your own. The right next step is a proper medical evaluation with a physician who specializes in hair loss. At The Gabel Center for Hair Restoration in Portland, Oregon, Dr. Gabel personally performs every consultation, examines the scalp in detail, and creates a treatment plan based on your specific diagnosis. Patients throughout Portland, Oregon, and the Pacific Northwest trust Dr. Gabel for honest answers and expert care. Contact The Gabel Center for Hair Restoration today to schedule your consultation with Dr. Gabel and take the first step toward understanding and treating your hair loss.
Reference
Burke O, Sa B, Alvarez Cespedes D, Sechi A, Tosti A. Glucagon-like peptide-1 receptor agonist medications and hair loss: A retrospective cohort study. Journal of the American Academy of Dermatology. 2025;92(5):1141-1143.
